Literature DB >> 23291779

The gut microbiota of a patient with resistant tuberculosis is more comprehensively studied by culturomics than by metagenomics.

G Dubourg1, J C Lagier, F Armougom, C Robert, I Hamad, P Brouqui, D Raoult.   

Abstract

Gut microbiota consists of 10(10) bacteria per gram of stool. Many antibiotic regimens induce a reduction in both the diversity and the abundance of the gut flora. We analyzed one stool sample collected from a patient treated for drug-resistant Mycobacterium tuberculosis and who ultimately died from pneumonia due to a Streptococcus pneumoniae 10 months later. We performed microscopic observation, used 70 culture conditions (microbial culturomics) with identification by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF) and 16S rRNA amplification and sequencing, pyrosequencing, and 18S rRNA amplification and clone sequencing. Electron and optical microscopic observations revealed the presence of yeast, but no bacterial species were observed. By culture, only 39 bacterial species were identified, including one new species, as well as three species that have not been previously observed in the human gut. The pyrosequencing showed only 18 phylotypes, detecting a lower number of bacterial species than the culture techniques. Only two phylotypes overlapped with culturomics. In contrast, an amount of chloroplasts was found. Additionally, specific molecular eukaryote detection found three fungal species. We recovered, for the first time, more cultivable than non-cultivable bacterial species in a patient with a low bacterial load in the gut, demonstrating the depth bias of pyrosequencing. We propose that the desertification of gut microbiota in this patient is a reflection of the total body microbiota and may have contributed to the invasive infection of S. pneumoniae. This finding suggests that caution should be applied when treating patients with broad-spectrum antibiotics, and preventive measures should be taken in order to avoid invasive infection.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23291779     DOI: 10.1007/s10096-012-1787-3

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  41 in total

1.  Organismal, genetic, and transcriptional variation in the deeply sequenced gut microbiomes of identical twins.

Authors:  Peter J Turnbaugh; Christopher Quince; Jeremiah J Faith; Alice C McHardy; Tanya Yatsunenko; Faheem Niazi; Jason Affourtit; Michael Egholm; Bernard Henrissat; Rob Knight; Jeffrey I Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  2010-04-02       Impact factor: 11.205

2.  Treatment of extensively drug-resistant tuberculosis.

Authors:  Jussara Munareto Silva; Sandra C Fuchs; Nêmora T Barcellos; Alexandre P Zavascki
Journal:  Lancet       Date:  2009-01-03       Impact factor: 79.321

3.  Antibiotic administration alters the community structure of the gastrointestinal micobiota.

Authors:  Courtney J Robinson; Vincent B Young
Journal:  Gut Microbes       Date:  2010-05-24

4.  Evaluation and improvement of real-time PCR assays targeting lytA, ply, and psaA genes for detection of pneumococcal DNA.

Authors:  Maria da Gloria S Carvalho; Maria Lucia Tondella; Karen McCaustland; Luciana Weidlich; Lesley McGee; Leonard W Mayer; Arnold Steigerwalt; Melissa Whaley; Richard R Facklam; Barry Fields; George Carlone; Edwin W Ades; Ron Dagan; Jacquelyn S Sampson
Journal:  J Clin Microbiol       Date:  2007-05-30       Impact factor: 5.948

5.  Human fecal flora: the normal flora of 20 Japanese-Hawaiians.

Authors:  W E Moore; L V Holdeman
Journal:  Appl Microbiol       Date:  1974-05

6.  Reproducible community dynamics of the gastrointestinal microbiota following antibiotic perturbation.

Authors:  Dionysios A Antonopoulos; Susan M Huse; Hilary G Morrison; Thomas M Schmidt; Mitchell L Sogin; Vincent B Young
Journal:  Infect Immun       Date:  2009-03-23       Impact factor: 3.441

7.  Protecting against pneumococcal disease: critical interactions between probiotics and the airway microbiome.

Authors:  Paul V Licciardi; Zheng Quan Toh; Eileen Dunne; Sook-San Wong; Edward K Mulholland; Mimi Tang; Roy M Robins-Browne; Catherine Satzke
Journal:  PLoS Pathog       Date:  2012-06-07       Impact factor: 6.823

8.  Development of the human infant intestinal microbiota.

Authors:  Chana Palmer; Elisabeth M Bik; Daniel B DiGiulio; David A Relman; Patrick O Brown
Journal:  PLoS Biol       Date:  2007-06-26       Impact factor: 8.029

9.  Non contiguous-finished genome sequence and description of Bacillus timonensis sp. nov.

Authors:  Sahare Kokcha; Ajay Kumar Mishra; Jean-Christophe Lagier; Matthieu Million; Quentin Leroy; Didier Raoult; Pierre-Edouard Fournier
Journal:  Stand Genomic Sci       Date:  2012-07-20

10.  Genome sequence and description of Alistipes senegalensis sp. nov.

Authors:  Ajay Kumar Mishra; Gregory Gimenez; Jean-Christophe Lagier; Catherine Robert; Didier Raoult; Pierre-Edouard Fournier
Journal:  Stand Genomic Sci       Date:  2012-07-20
View more
  66 in total

Review 1.  The Human Microbiome in the Fight Against Tuberculosis.

Authors:  Madeleine R Wood; Elaine A Yu; Saurabh Mehta
Journal:  Am J Trop Med Hyg       Date:  2017-06       Impact factor: 2.345

2.  Culturomics identified 11 new bacterial species from a single anorexia nervosa stool sample.

Authors:  A Pfleiderer; J-C Lagier; F Armougom; C Robert; B Vialettes; D Raoult
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-06-02       Impact factor: 3.267

3.  Molecular studies neglect apparently gram-negative populations in the human gut microbiota.

Authors:  Perrine Hugon; Jean-Christophe Lagier; Catherine Robert; Catherine Lepolard; Laurent Papazian; Didier Musso; Bernard Vialettes; Didier Raoult
Journal:  J Clin Microbiol       Date:  2013-07-24       Impact factor: 5.948

4.  The rebirth of culture in microbiology through the example of culturomics to study human gut microbiota.

Authors:  Jean-Christophe Lagier; Perrine Hugon; Saber Khelaifia; Pierre-Edouard Fournier; Bernard La Scola; Didier Raoult
Journal:  Clin Microbiol Rev       Date:  2015-01       Impact factor: 26.132

5.  Progress in metagenomics requires a balanced appraisal of the available technologies.

Authors:  J F Huggett; D J Studholme; T Laver; C A Foy
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-02-23       Impact factor: 3.267

6.  The proof of concept that culturomics can be superior to metagenomics to study atypical stool samples.

Authors:  G Dubourg; J C Lagier; F Armougom; C Robert; I Hamad; P Brouqui; D Raoult
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-02-21       Impact factor: 3.267

7.  Identification of rare pathogenic bacteria in a clinical microbiology laboratory: impact of matrix-assisted laser desorption ionization-time of flight mass spectrometry.

Authors:  Piseth Seng; Cedric Abat; Jean Marc Rolain; Philippe Colson; Jean-Christophe Lagier; Frédérique Gouriet; Pierre Edouard Fournier; Michel Drancourt; Bernard La Scola; Didier Raoult
Journal:  J Clin Microbiol       Date:  2013-05-01       Impact factor: 5.948

Review 8.  The first 1000 cultured species of the human gastrointestinal microbiota.

Authors:  Mirjana Rajilić-Stojanović; Willem M de Vos
Journal:  FEMS Microbiol Rev       Date:  2014-06-27       Impact factor: 16.408

9.  Does a learned journal require regular re-vamping?

Authors:  A van Belkum
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-08       Impact factor: 3.267

10.  Clostridium culturomicium sp. nov. and Clostridium jeddahitimonense sp. nov., novel members of the Clostridium genus isolated from the stool of an obese Saudi Arabian.

Authors:  Hoang Thong Kieu; Noémie Garrigou; Amael Fadlane; Ludivine Brechard; Nicholas Armstrong; Philippe Decloquement; Muhammad Yasir; Esam Ibraheem Azhar; Saad B Al-Masaudi; Jean-Christophe Lagier; Maryam Tidjani Alou; Didier Raoult
Journal:  Curr Microbiol       Date:  2021-07-23       Impact factor: 2.188

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.